Hans M Kvasnicka Selected Research

Hans M Kvasnicka Research Topics

4	Neoplasms (Cancer) 12/2023 - 01/2013
4	Primary Myelofibrosis (Myelosclerosis) 09/2009 - 04/2004
2	Fibrosis (Cirrhosis) 11/2022 - 04/2004
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2007 - 02/2003
1	Eosinophilia 12/2023
1	Measles 10/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2022
1	Human Influenza (Influenza) 11/2022
1	COVID-19 11/2022
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Carcinogenesis 01/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014
1	Brain Neoplasms (Brain Tumor) 01/2014
1	Leukocytosis (Pleocytosis) 09/2009
1	Anemia 09/2009
1	Prodromal Symptoms 01/2007
1	Stroke (Strokes) 10/2005
1	Essential Thrombocythemia 10/2005
1	Leukemia 04/2004

2	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2014
2	Reticulin (Reticular Fiber)IBA 01/2007 - 04/2004
2	CollagenIBA 01/2007 - 04/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2023
1	Carcinoembryonic AntigenIBA 10/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2023
1	VaccinesIBA 10/2023
1	CytokinesIBA 10/2023
1	Messenger RNA (mRNA)IBA 11/2022
1	Complement C3 (C3 Complement)IBA 11/2022
1	Netrin-1IBA 01/2014
1	anagrelide (Agrylin)FDA LinkGeneric 01/2013
1	Prednisone (Sone)FDA LinkGeneric 09/2009
1	Thalidomide (Thalomid)FDA Link 09/2009
1	Lenalidomide (CC 5013)FDA Link 09/2009
1	pomalidomideIBA 09/2009
1	InterferonsIBA 10/2005
1	Phenobarbital (Luminal)FDA Link 08/2005
1	Muramidase (Lysozyme)IBA 04/2004
1	IronIBA 04/2004

3	Therapeutics 11/2022 - 10/2005
1	Lasers (Laser) 11/2022
1	Synchrotrons 11/2022
1	Homologous Transplantation 02/2003